Droplet digital polymerase chain reaction assay for screening of ESR1 mutations in 325 breast cancer specimens-Reference-Cited by-同舟云学术

Droplet digital polymerase chain reaction assay for screening of ESR1 mutations in 325 breast cancer specimens

Published:2015-12 Issue:6 Volume:166 Page:540-553.e2
ISSN:1931-5244
Container-title:Translational Research
language:en
Short-container-title:Translational Research

Author:

Takeshita Takashi,Yamamoto Yutaka,Yamamoto-Ibusuki Mutsuko,Inao Toko,Sueta Aiko,Fujiwara Saori,Omoto Yoko,Iwase Hirotaka

Funder

Ministry of Education, Science and Culture of Japan

Publisher

Elsevier BV

Subject

Biochemistry (medical),Public Health, Environmental and Occupational Health,General Medicine,Physiology (medical)

Reference30 articles.

1. Current topics and perspectives on the use of aromatase inhibitors in the treatment of breast cancer;Iwase;Breast Cancer,2008

2. Anastrozole alone or in combination with tamoxifen versus tamoxifen alone for adjuvant treatment of postmenopausal women with early breast cancer: first results of the ATAC randomised trial;Baum;Lancet,2002

3. Estrogen receptor mutations found in breast cancer metastases integrated with the molecular pharmacology of selective ER modulators;Jordan;J Natl Cancer Inst,2015

4. Inhibition of estrogen receptor action by a naturally occurring variant in human breast tumors;Fuqua;Cancer Res,1992

5. Constitutively active human estrogen receptors containing amino acid substitutions for tyrosine 537 in the receptor protein;Weis;Mol Endocrinol,1996

Cited by 58 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Estrogen Receptor Alpha Mutations, Truncations, Heterodimers, and Therapies;Endocrinology;2024-04-21

2. Rare subclonal sequencing of breast cancers indicates putative metastatic driver mutations are predominately acquired after dissemination;Genome Medicine;2024-02-06

3. c-MET-positive circulating tumor cells and cell-free DNA as independent prognostic factors in hormone receptor-positive/HER2-negative metastatic breast cancer;Breast Cancer Research;2024-01-18

4. Addressing ESR1 Mutation: A Key Factor in Hormone Therapy Resistance in Breast Cancer;Interdisciplinary Cancer Research;2024

5. Validation of liquid biopsy for ESR1-mutation analysis in hormone-sensitive breast cancer: a pooled meta-analysis;Frontiers in Oncology;2023-08-22